【摘要】：G protein-coupled receptors(GPCRs)convert extracellular stimuli in the form of hormones,odorants and light into profound changes in cell homeostasis.Their timely desensitization is critical for cells to rapidly respond to changes in their environment and to avoid damage from sustained signaling.Seven GPCR kinases(GRKs)phosphorylate and regulate the activity of most of the~800 GPCRs in the human genome.Although GRKs normally play an adaptive role,in conditions such as chronic heart failure they are overexpressed and linked to disease progression.GRK2 and GRK5 have thus become important targets for the treatment of heart failure and pathological cardiac hypertrophy,respectively.Our lab has determined atomic structures representing all three vertebrate GRK subfamilies,and is now in the midst of a campaign to develop selective inhibitors of these enzymes using structure-based rational design.We have identified the FDA approved drug paroxetine as a selective GRK2 inhibitor,determined the crystal structure of the GRK2·paroxetine complex and,in collaboration with the Koch lab,showed that the drug improves contractility in myocytes and,most impressively,recovery in postmyocardial infarcted mice.Since then,we have identified additional chemical scaffolds that exhibit even higher potency and/or selectivity for GRK5.Using a"hybrid"inhibitor design approach we have generated GRK selective chemical probes that exhibit improved potency and stability and are able to increase inotropy and dampen the hypertrophic response in cardiomyocytes and small animal models.Structural analysis has revealed the molecular basis for selectivity and potency in many of these compounds,allowing for the design of future generations of GRK chemical probes.

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 戴德哉;Vascular selectivity of felodipine[J];Acta Pharmacologica Sinica;1996年01期

2 ZC Xin,EK Kim,CS Lin,WJ Liu,L Tian,YM Yuan,J Fu;Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities[J];Asian Journal of Andrology;2003年01期

3 韋日生;賀師鵬;;GPCRs的變構(gòu)調(diào)節(jié)劑與藥物新靶點[J];生理科學(xué)進(jìn)展;2012年06期

4 Jamshed Haneef;Mohammad Shaharyar;Asif Husain;Mohd Rashid;Ravinesh Mishra;Shama Parveen;Niyaz Ahmed;Manoj Pal;Deepak Kumar;;Application of LC MS/MS for quantitative analysis of glucocorticoids and stimulants in biological fuids[J];Journal of Pharmaceutical Analysis;2013年05期

5 Dong-soon IM;;Two ligands for a GPCR,proton vs lysolipid[J];Acta Pharmacologica Sinica;2005年12期

6 Baloucoune Guillaume Antoine;肖勝杰;蔣明;皮振鈞;黃思羅;;GPCRs組成性活性的研究進(jìn)展及意義[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年19期

7 DU Bing;LIU MingYao;;Structure of the human P2Y_(12) receptor in complex with an antithrombotic drug[J];Science China(Life Sciences);2014年06期

8 阮嬪;趙菡;薛禮;蔣明;黃思羅;;C族GPCRs的半胱氨酸富集區(qū)的研究進(jìn)展及藥學(xué)意義[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年09期

9 Fuad Al-Rimawi;Wahbeh Zareer;Salah Rabie;Mazen Quod;;Development and validation of a reversed-phase HPLC method for analysis of tetrahydrozoline hydrochloride in eye drop formulations[J];Journal of Pharmaceutical Analysis;2012年01期

10 姚立新;;現(xiàn)代藥物設(shè)計傳統(tǒng)理論受到挑戰(zhàn)[J];廣東藥學(xué)院學(xué)報;2010年05期

相關(guān)會議論文 前10條

1 ;Structure basis for Herbicidal inhibitor selectivity to plant 4-hydroxyphenylpyruvate dioxygenases and the method of drug discovery:Fragment-based Screening[A];第十次中國生物物理學(xué)術(shù)大會論文摘要集[C];2006年

2 ;High through-put screening,single channel analysis & crystal structure reveal the selectivity,conductance and pharmacological binding sites of ion channels[A];中國藥理學(xué)會第十一次全國學(xué)術(shù)會議專刊[C];2011年

3 ;Structural basis for the selectivity of Gleevec[A];中國化學(xué)會第九屆全國量子化學(xué)學(xué)術(shù)會議暨慶祝徐光憲教授從教六十年論文摘要集[C];2005年

4 來魯華;;從基于結(jié)構(gòu)到基于系統(tǒng)的藥物設(shè)計(英文)[A];第六屆全國化學(xué)生物學(xué)學(xué)術(shù)會議論文摘要集[C];2009年

5 萬曉霞;;國內(nèi)外藥物設(shè)計文獻(xiàn)對比研究分析[A];中國藥理學(xué)會制藥工業(yè)專業(yè)委員會第十一屆學(xué)術(shù)會議論文摘要匯編[C];2004年

6 苑亞夏;裴劍鋒;來魯華;;基于結(jié)構(gòu)的全新藥物設(shè)計方法[A];第一屆全國生物物理化學(xué)會議暨生物物理化學(xué)發(fā)展戰(zhàn)略研討會論文摘要集[C];2010年

7 徐志建;劉正;陳彤;陳甜甜;劉正;田廣輝;石靜;王雪蘭;盧運祥;閆秀花;王貫;蔣華良;陳凱先;王淑東;許葉春;沈敬山;朱維良;;鹵鍵在藥物設(shè)計中的應(yīng)用[A];第十一屆全國計算（機(jī)）化學(xué)學(xué)術(shù)會議論文摘要集[C];2011年

8 郭宗儒;;分子多樣性、互補性和相似性-藥物設(shè)計的策略基礎(chǔ)[A];第七屆全國生化藥理學(xué)術(shù)討論會論文摘要集[C];2000年

9 劉克良;周寧;周文霞;謝劍煒;;抗蛋白酶降解的長效肽類藥物設(shè)計及作用機(jī)制研究[A];2006第六屆中國藥學(xué)會學(xué)術(shù)年會論文集[C];2006年

10 張國棟;溫創(chuàng)宇;劉煥亮;徐峻;;以β-葡萄糖醛酸酶為靶標(biāo)的抗癌助劑的藥物設(shè)計[A];中國化學(xué)會第28屆學(xué)術(shù)年會第14分會場摘要集[C];2012年

相關(guān)重要報紙文章 前1條

1 記者 陶婷婷;藥物設(shè)計新方法可預(yù)測藥效[N];上海科技報;2013年

相關(guān)碩士學(xué)位論文 前3條

1 惠文其;三種與神經(jīng)退行性疾病相關(guān)的GPCRs的合理藥物設(shè)計[D];第三軍醫(yī)大學(xué);2016年

2 李保坤;GPCRs配體小分子的計算機(jī)模擬與藥物設(shè)計[D];蘇州大學(xué);2013年

3 張賀;基于細(xì)菌分裂蛋白FtsZ靶點的藥物設(shè)計及生物活性研究[D];天津理工大學(xué);2015年

，

本文編號：2584290